Skip to main content
. 2021 Nov 8;12:736301. doi: 10.3389/fphar.2021.736301

FIGURE 8.

FIGURE 8

The immunohistochemical BMP-2, osteocalcin (OCN), and CD31 examinations of the osteogenic potential of control, PLLA, PLLA/LC, and HAP-PLLA/LC, respectively, were performed at 4, 8, and 12 weeks. The quantified analysis of (D) BMP-2, (E) OCN, and (F) CD31 at 4, 8, and 12 weeks after surgery.